Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Longitudinal Observational Follow-up of the PRECEPT Study Cohort

Study:

A Longitudinal Observational Follow-up of the PRECEPT Study Cohort

Rationale:

n/a

Purpose:

The purpose of this study is to longitudinally follow consenting clinical trial participants who participated in PRECEPT (A Randomized, Double Blind, Placebo Controlled, Dose Finding Study to Assess the Efficacy and Safety of CEP 1347 in Patients With Early Parkinson`s Disease). The study will assess the clinical and imaging outcomes relevant to the natural history of Parkinson`s disease (PD), as well as determine early biomarkers of the disease.

Study Status: Enrolling by invitation

Recruiting:
n/a

Condition Intervention Phase
Parkinson Disease n/a N/A

Verified by The Parkinson Study Group March, 2008

Sponsored by: The Parkinson Study Group
Information provided by: The Parkinson Study Group
ClinicalTrials.gov identifier: NCT00605163

Study Type: Interventional

Study Design: Cohort, Other

Cleveland Clinic Florida-Weston
Weston, Florida
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site